Increased patient co-payments and changes in PBS-subsidised prescription medicines dispensed in Western Australia

Aust N Z J Public Health. 2009 Jun;33(3):246-52. doi: 10.1111/j.1753-6405.2009.00383.x.


Objective: To determine whether a 24% increase in patient co-payments in January 2005 and two related co-payment changes for medicines subsidised under the Australian Pharmaceutical Benefits Scheme (PBS) were associated with changes in dispensings in Western Australia (WA).

Method: We analysed aggregate monthly prescription counts and defined daily dose per 1,000 population per day (DDD/1,000/day) for atypical antipsychotics, combination asthma medicines, HmgCoA reductase inhibitors (statins) and proton-pump inhibitors (PPIs). Trends pre and post the co-payment increase in January 2005 were compared.

Results: In three of the four categories examined, prescription counts were significantly lower following the increase in co-payment thresholds. Compared with dispensings prior to the co-payment increase, prescriptions fell by 8% for combination asthma medicines (p<0.001), 9% for PPIs (p<0.001) and 5% for statins (p<0.001). Following the rise in co-payments, DDD/1,000/day decreased for all four categories. Decreases in dispensings to concessional beneficiaries were between 4% and 5% larger than for general beneficiary patients.

Conclusions and implications: The reduction in the both prescription counts and DDD/1,000/day observed for combination asthma medicines, PPIs and statins, which all remained above co-payment thresholds, suggests the increase in PBS co-payments has affected utilisation of these subsidised medicines. The results indicate that increases in patient contributions particularly impact on concessional patients' ability to afford prescription medicines.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cost Sharing / economics*
  • Cost Sharing / trends
  • Databases as Topic
  • Financing, Government
  • Humans
  • Insurance, Pharmaceutical Services / economics*
  • National Health Programs / economics
  • Pharmaceutical Preparations / economics*
  • Western Australia


  • Pharmaceutical Preparations